Creative Planning’s ImmuCell ICCC Stock Holding History

Creative Planning’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-310	Closed	-$2K	–	4652
2016 Q2	$2K	Hold	310	–	–	﹤0.01%	4018
2016 Q1	$2K	Hold	310	–	–	﹤0.01%	3949
2015 Q4	$2K	Hold	310	–	–	﹤0.01%	4025
2015 Q3	$2K	Buy	+310	New	+$2.53K	﹤0.01%	3941
2015 Q2	–	Sell	-310	Closed	-$2K	–	1955
2015 Q1	$2K	Hold	310	–	–	﹤0.01%	3873
2014 Q4	$2K	Hold	310	–	–	﹤0.01%	3819
2014 Q3	$2K	Hold	310	–	–	﹤0.01%	3660
2014 Q2	$1K	Hold	310	–	–	﹤0.01%	3634
2014 Q1	$1K	Hold	310	–	–	﹤0.01%	3498
2013 Q4	$1K	Hold	310	–	–	﹤0.01%	3209
2013 Q3	$1K	Hold	310	–	–	﹤0.01%	3088
2013 Q2	$1K	Buy	+310	New	+$1.11K	﹤0.01%	2941

Other funds holding ICCC

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Creative Planning's ICCC Position: Q3 2016 in Review

Creative Planning sold out of ImmuCell (ICCC) in Q3 2016, closing a stake of 310 shares — an estimated $2K sold.

Creative Planning first reported a position in ICCC in Q2 2013 and held it in 12 quarters. The position peaked at $2K in Q2 2016. 19 funds tracked by Wall St. Rank hold ICCC as of Q3 2016.

Creative Planning reported no remaining ImmuCell position as of Q3 2016 after selling out during the quarter.
Creative Planning sold 310 ImmuCell shares in Q3 2016, an estimated $2K.
Creative Planning first reported a position in ImmuCell in Q2 2013 and held it in 12 quarters.
Creative Planning's ImmuCell position peaked at $2K in Q2 2016.
19 funds tracked by Wall St. Rank held ImmuCell as of Q3 2016.

Based on Creative Planning's 13F filing for Q3 2016, filed 12 Oct 2016.